Moreover, a study examining the clinical data, routine blood counts, and responses to granulocyte-colony stimulating factor therapy from 88 affected BTHS boys concluded that susceptibility to infections was due only in part to neutropenia since in some instances infection occurred despite consistent prevention of neutropenia by granulocyte-colony-stimulating factor therapy [9]. This evidence concerns the gene CSF3 and neutropenia.